Long-term Evaluation of Single-piece ACrysof IOL Implantation on Development of Posterior Capsule Opacification

Sponsor
Iladevi Cataract and IOL Research Center (Other)
Overall Status
Completed
CT.gov ID
NCT01820065
Collaborator
(none)
390
1
76
5.1

Study Details

Study Description

Brief Summary

Although contemporary cataract surgery has made tremendous strides in technological advancement, posterior capsular opacification (PCO) is still the most frequent long-term complication leading to decreased visual functions and thereby dissatisfying results. A great deal of effort has been made to develop new ways to prevent the formation of PCO. A key factor, widely discussed in literature, is the material and design of the intraocular lense (IOL) edge that can lead to PCO prevention. It is still not clear whether the sharp-edged IOL produces less PCO because of its optic geometry alone or whether the biomaterial contributes to the inhibition of PCO. With the clinical introduction of the single-piece acrylic hydrophobic IOLs with some optic and haptic design differences compared with three-piece acrylic hydrophobic IOLs, it has become possible to determine the influence of IOL material and design on PCO prevention. It is well established that the development of PCO is a dynamic process and that a longer follow-up time is correlated with a higher degree of PCO. So far, there have been prospective clinical studies on the clinical results of single and three-piece acrylic hydrophobic foldable IOLs. However, the question as to as to whether the PCO further increases or becomes stable or regresses on a long-term basis has not yet been answered. Since there is paucity of available literature that prospectively evaluates the development of PCO with the implantation of the single-piece SN60AT hydrophobic acrylic IOL on a long-term basis, the investigators decided to observe the degree of development of PCO at 5 years after cataract surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cataract surgery with IOL implantation

Study Design

Study Type:
Observational
Actual Enrollment :
390 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Long-term Evaluation of Single-piece Hydrophobic Acrylic Intraocular Lens Implantation on the Development of Posterior Capsule Opacification
Study Start Date :
Jun 1, 2005
Actual Primary Completion Date :
Oct 1, 2011
Actual Study Completion Date :
Oct 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Patients undergoing phacoemulsification

Patients undergoing phacoemulsification for age-related cataract with implantation of a single-piece Acrysof IOL (SN60AT)

Procedure: Cataract surgery with IOL implantation
Phacoemulsification with implantation of single piece Acrysof IOL

Outcome Measures

Primary Outcome Measures

  1. Posterior Capsule Opacification [5 years followup]

    Evaluation of PCO (EPCO) scores in the area of the intraocular lens (IOL) optic and in the central 3mm zone at 5 years after surgery

Secondary Outcome Measures

  1. EPCO Score and EPCO area with total on and part on anterior capsulorhexis cover over optic [5 years postoperatively]

Other Outcome Measures

  1. Change in PCO at different followup intervals [upto 5 years postoperatively]

    Change in PCO observed from 1 month to 1 year, 1 year to 3 years, and 3 years to 5 years

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with uncomplicated age-related cataract who were otherwise healthy
Exclusion Criteria:
  • a history of diabetes mellitus (DM),

  • patients with glaucoma,

  • high myopia (axial length > 27.0 mm),

  • pseudoexfoliation,

  • traumatic cataract,

  • subluxated cataract,

  • previous ocular surgeries, and

  • allergy to dilating drops.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Iladevi Cataract & IOL Research Centre Ahmedabad Gujarat India 380052

Sponsors and Collaborators

  • Iladevi Cataract and IOL Research Center

Investigators

  • Principal Investigator: Abhay R Vasavada, MS, FRCS, Iladevi Cataract & IOL Research Centre
  • Principal Investigator: Abhay R Vasavada, MS,FRCS, Iladevi Cataract & IOL Research Centre

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Abhay R. Vasavada, Director, Iladevi Cataract and IOL Research Center, Iladevi Cataract and IOL Research Center
ClinicalTrials.gov Identifier:
NCT01820065
Other Study ID Numbers:
  • 05-003
First Posted:
Mar 28, 2013
Last Update Posted:
Mar 28, 2013
Last Verified:
Mar 1, 2013
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 28, 2013